QLGN
Price:
$3.21
Market Cap:
$7.17M
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressin...[Read more]
Industry
Biotechnology
IPO Date
2015-06-23
Stock Exchange
NASDAQ
Ticker
QLGN
According to Qualigen Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -94.09%. This represents a change of -1313.59% compared to the average of 7.75% of the last 4 quarters.
The mean historical ROE of Qualigen Therapeutics, Inc. over the last ten years is -72.76%. The current -94.09% ROE has changed 29.32% with respect to the historical average. Over the past ten years (40 quarters), QLGN's ROE was at its highest in in the March 2019 quarter at 374.04%. The ROE was at its lowest in in the March 2025 quarter at -7986.27%.
Average
-72.76%
Median
-109.83%
Minimum
-921.20%
Maximum
810.38%
Discovering the peaks and valleys of Qualigen Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 648.76%
Maximum Annual ROE = 810.38%
Minimum Annual Increase = -2418.13%
Minimum Annual ROE = -921.20%
| Year | ROE | Change |
|---|---|---|
| 2025 | -60.70% | -74.02% |
| 2024 | -233.64% | -136.63% |
| 2023 | 637.83% | -347.59% |
| 2022 | -257.62% | 138.44% |
| 2021 | -108.04% | -3.20% |
| 2020 | -111.61% | -87.88% |
| 2019 | -921.20% | -213.68% |
| 2019 | 810.38% | -2418.13% |
| 2018 | -34.96% | -92.20% |
| 2016 | -448.07% | 648.76% |
The current ROE of Qualigen Therapeutics, Inc. (QLGN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
114.50%
5-year avg
-4.43%
10-year avg
-72.76%
Qualigen Therapeutics, Inc.’s ROE is greater than Soligenix, Inc. (-246.04%), greater than Oragenics, Inc. (-177.32%), less than Titan Pharmaceuticals, Inc. (1.94%), greater than Can-Fite BioPharma Ltd. (-141.01%), greater than Xenetic Biosciences, Inc. (-39.28%), greater than Kazia Therapeutics Limited (-116.86%), greater than Ensysce Biosciences, Inc. (-631.47%), greater than CNS Pharmaceuticals, Inc. (-238.69%), greater than Clearmind Medicine Inc. (-182.45%), greater than KALA BIO, Inc. (-1335.64%),
| Company | ROE | Market cap |
|---|---|---|
| -246.04% | $4.43M | |
| -177.32% | $2.81M | |
| 1.94% | $3.11M | |
| -141.01% | $1.53M | |
| -39.28% | $6.04M | |
| -116.86% | $23.13M | |
| -631.47% | $2.33M | |
| -238.69% | $2.81M | |
| -182.45% | $3.40M | |
| -1335.64% | $57.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qualigen Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Qualigen Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Qualigen Therapeutics, Inc.'s ROE?
How is the ROE calculated for Qualigen Therapeutics, Inc. (QLGN)?
What is the highest ROE for Qualigen Therapeutics, Inc. (QLGN)?
What is the 3-year average ROE for Qualigen Therapeutics, Inc. (QLGN)?
What is the 5-year average ROE for Qualigen Therapeutics, Inc. (QLGN)?
How does the current ROE for Qualigen Therapeutics, Inc. (QLGN) compare to its historical average?